Cite

HARVARD Citation

    Li, Z. et al. (2022). Batch-to-batch consistency trial of an adenovirus type-5 vector-based COVID-19 vaccine in adults aged 18 years and above. Expert review of vaccines. pp. 1843-1849. [Online]. 
  
Back to record